Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

By sjmartinez • August 15, 2024

Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241259905. doi: 10.1177/21501319241259905. PMID: 39143759.

Tags: Chronic kidney disease, consensus, KDIGO, Nephrology, Publications, SGLT2 inhibitor, treatment algorithm

Hormones and Nephrons: Disentangling the Thyroid-Kidney Connection

Rhee CM, Narasaki Y. Hormones and Nephrons: Disentangling the Thyroid-Kidney Connection. Clin J Am Soc Nephrol. 2025 Jun 12. doi: 10.2215/CJN.0000000761. Epub ahead of print.[...]

How I Treat a Hospitalized Patient Receiving Peritoneal Dialysis

Shah AP, Dai T, Dukkipati R. How I Treat a Hospitalized Patient Receiving Peritoneal Dialysis. Clin J Am Soc Nephrol. 2025 Jun 11. doi: 10.2215/CJN.0000000783.[...]

Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study

Tuttle KR, Reynolds CL, Kornowske LM, Jones CR, Alicic RZ, Daratha KB, Neumiller JJ, Greenbaum C, Pavkov ME, Xu F, Duru OK, Nicholas SB, Norris[...]